tiprankstipranks
Trending News
More News >
Spero Therapeutics Inc (SPRO)
NASDAQ:SPRO
US Market

Spero Therapeutics (SPRO) Income Statement

Compare
580 Followers

Spero Therapeutics Income Statement

Last quarter (Q3 2025), Spero Therapeutics's total revenue was $3.05M, a decrease of -77.37% from the same quarter last year. In Q3, Spero Therapeutics's net income was $-7.38M. See Spero Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 47.98M$ 103.78M$ 48.58M$ 3.07M$ 9.33M
Gross Profit
$ -48.78M$ 52.34M$ 48.58M$ 3.07M$ -57.67M
Operating Expenses
$ 24.58M$ 30.86M$ 90.78M$ 91.04M$ 21.44M
Depreciation and Amortization
$ 2.00K$ 367.00K$ 869.00K$ 646.00K$ 761.00K
EBITDA
$ -72.48M$ 27.15M$ -42.94M$ -87.17M$ -78.35M
Operating Income
$ -73.36M$ 21.48M$ -42.20M$ -87.97M$ -79.11M
Other Income/Expenses
$ 4.79M$ 3.92M$ -4.22M$ -1.78M$ 833.00K
Pretax Income
$ -68.57M$ 25.40M$ -46.41M$ -89.76M$ -78.28M
Net Income
$ -68.57M$ 22.81M$ -46.41M$ -89.76M$ -78.28M
Per Share Metrics
Basic EPS
$ -1.27$ 0.43$ -1.23$ -2.91$ -3.52
Diluted EPS
$ -1.27$ 0.43$ -1.23$ -2.91$ -3.52
Weighted Average Shares Outstanding
54.04M 52.70M 37.59M 30.90M 22.39M
Weighted Average Shares Outstanding (Diluted)
54.04M 52.99M 37.59M 30.90M 22.39M
Currency in USD

Spero Therapeutics Earnings and Revenue History